- CA$144.86m
- CA$113.85m
- 52
- 49
- 74
- 60
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.17 | 4.14 | 2.76 | 3.95 | 3.6 |
Operating Profit | -5.17 | -4.14 | -2.76 | -3.95 | -3.6 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.65 | -5.29 | 11.5 | -5.91 | -3.37 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.93 | -3.74 | 20.9 | -8.39 | 4.42 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.93 | -3.74 | 20.9 | -8.39 | 4.42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.93 | -3.74 | 20.9 | -8.39 | 4.42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.017 | -0.007 | 0.059 | -0.032 | 0.012 |